BPC-157 10mg

Sold for laboratory research use only. Not for human or veterinary use

£27.95

Research Use Only

BPC-157 (Body Protection Compound-157) is a synthetic peptide fragment consisting of 15 amino acids, derived from a sequence originally identified in human gastric juice. It is supplied exclusively for laboratory research purposes.

 

In research settings, BPC-157 is commonly utilised as a model peptide in experimental studies exploring peptide stability, molecular signalling pathways, and peptide–tissue interactions under controlled laboratory conditions. Its relatively short chain length and defined amino acid sequence make it of interest in in vitro and preclinical research environments focused on peptide behaviour and structure–function relationships.

This compound is frequently referenced in the scientific literature as a tool compound in experimental research, where it has been investigated in a variety of non-clinical models. Researchers may employ BPC-157 in studies examining biochemical mechanisms, cellular responses, or comparative peptide analysis, depending on their specific research objectives.

Product Information

Important Notice

This product is supplied strictly for research use only.
It is not intended for human or veterinary use, and is not a medicinal product, food supplement, or cosmetic ingredient.
No claims are made regarding safety, efficacy, or suitability for any therapeutic, diagnostic, or consumable application.

Batch Number: BC10/2025-04

View Certificate of Analysis:

Quick Payment

99%+ purity

Fast Delivery

WhatsApp Image 2026-01-28 at 11.18.58 PM (1)

Welcome to PeptideHub

By entering this website, you confirm that you are 18 years of age or older.

All products offered by PeptideHub are supplied strictly for laboratory and in-vitro research use only.

These products are:

  • Not for human or veterinary use
  • Not for human consumption
  • Not intended for diagnosis, treatment, cure, or prevention of disease
  • Not marketed or sold as medicinal products

 

By clicking AGREE, you confirm that you understand and accept these terms.